Patient
SITE001-0078
enrolled Phase IIIA Phase III, Randomized, Double-Blind Study of Torivumab Plus Chemotherapy Versus Placebo Plus Chemotherapy in Previously Untreated Advanced Non-Small Cell Lung Cancer · SITE001 (USA) (Dr. Reyes)
consented 2025-12-02
Adverse events
4
Serious AEs
0
Open data queries
0
Luna dropout signal
—
not on Luna
Adverse events 4
Grade 2 Alopecia — outcome: RECOVERED/RESOLVED; onset 2022-07-24 (study day 49); relationship: not assessed
Grade 2 Alopecia — outcome: RECOVERED/RESOLVED; onset 2022-07-19 (study day 44); relationship: NOT RELATED
Grade 2 Anaemia — outcome: RECOVERED/RESOLVED; onset 2022-07-14 (study day 39); relationship: NOT RELATED
Grade 1 Peripheral neuropathy — outcome: RECOVERED/RESOLVED; onset 2022-06-19 (study day 14); relationship: not assessed
Data queries 0
No data queries
The CDM sweep raises queries on inconsistent fields.
Luna engagement
This participant doesn't use Luna
Invite them from the site to track mood, adherence and check-ins.